RxDoctor Payments Data

David Hammett

Neurology · Columbia, SCNPI 1154412229

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $70,470 of the $86,084 with a category attached, or 81.9%. AbbVie accounts for 63.9% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2021 at $45,955 and has fallen 98.2% since, to $829 in 2023. Among neurology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,084in general payments, 2019–2025

Across 733 payments — averaging $117.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$55K
  • Teva Pharmaceuticals USA, Inc.$18K
  • Biohaven Pharmaceuticals, Inc.$9K
  • Amgen$508
  • Supernus Pharmaceuticals, Inc.$446
  • Lilly USA, LLC$420
  • plus $3K from 29 others

What the payments were for

  • Consulting fees$3,6504%
  • Speaking & faculty fees$70,47082%
  • Travel & lodging$1,1761%
  • Food & beverage$10,77113%
  • Education$160%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,084 in reported general payments places this provider in the 95th percentile of 270 neurology providers in South Carolina.

See all neurology providers in South Carolina

Other neurology in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →